BOSE AMOSUN: Open Payments
NPI 1962283622 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,608 in 53 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $1,268 · 2025 $1,608
Food & beverage: $1,608
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $382 |
| ABBVIE INC. | 10 | $339 |
| Aimmune Therapeutics, Inc. | 8 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $169 |
| PFIZER INC. | 8 | $149 |
| Phathom Pharmaceuticals, Inc. | 4 | $84 |
| Ipsen Biopharmaceuticals, Inc | 2 | $50 |
| GENZYME CORPORATION | 1 | $45 |
| Madrigal Pharmaceuticals | 1 | $37 |
| Braintree Laboratories, Inc. | 2 | $34 |
Products named: TREMFYA, CREON, ENTYVIO, ZENPEP, VELSIPITY, LINZESS, VOQUEZNA, RINVOQ.
Industry payments across WA — which companies pay providers there.
